BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8054405)

  • 1. Disruption of circadian MHPG rhythmicity in major depression.
    Piletz JE; DeMet E; Gwirtsman HE; Halaris A
    Biol Psychiatry; 1994 Jun; 35(11):830-42. PubMed ID: 8054405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent phase advance in diurnal MHPG rhythm in depression.
    Gwirtsman HE; Halaris AE; Wolf AW; DeMet E; Piletz JE; Marler M
    Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of desipramine on diurnal rhythms of plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in depressed patients.
    DeMet EM; Halaris AE; Gwirtsman HE; Reno RM; Becker PI
    Psychopharmacol Bull; 1982 Oct; 18(4):221-3. PubMed ID: 6891473
    [No Abstract]   [Full Text] [Related]  

  • 4. MHPG circadian rhythmicity in blood of healthy subjects.
    Marler M; Halaris A; Piletz JE
    Chronobiologia; 1990; 17(2):117-34. PubMed ID: 2394197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings.
    Muscettola G; Potter WZ; Pickar D; Goodwin FK
    Arch Gen Psychiatry; 1984 Apr; 41(4):337-42. PubMed ID: 6703853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients.
    Karege F; Bovier P; Gaillard JM; Tissot R
    Acta Psychiatr Scand; 1989 Nov; 80(5):499-504. PubMed ID: 2596350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
    Halbreich U; Sharpless N; Asnis GM; Endicott J; Goldstein S; Vital-Herne J; Eisenberg J; Zander K; Kang BJ; Shindledecker R
    Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
    Azorin JM; Raucoules D; Valli M; Levy C; Lancon C; Luccioni JM; Tissot R
    Neuropsychobiology; 1990; 23(1):18-24. PubMed ID: 2280827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma MHPG in depression: effects of acute and chronic desipramine treatment.
    Charney DS; Heninger GR; Sternberg DE; Roth RH
    Psychiatry Res; 1981 Oct; 5(2):217-29. PubMed ID: 6945615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet membrane alpha 2-adrenergic receptors in depression.
    Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
    Psychiatry Res; 1992 Sep; 43(3):243-52. PubMed ID: 1359596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression.
    Koenigsberg HW; Teicher MH; Mitropoulou V; Navalta C; New AS; Trestman R; Siever LJ
    J Psychiatr Res; 2004; 38(5):503-11. PubMed ID: 15380401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal variation in total plasma tryptophan in controls and in depression.
    Candito M; SouĂȘtre E; Iordache A; Pringuey D; Ardisson JL; Chambon P; Darcourt G
    J Psychiatr Res; 1990; 24(3):227-30. PubMed ID: 2266511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
    Ko HC; Lu RB; Shiah IS; Hwang CC
    Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-free and sulfoconjugated MHPG in major depressive disorders: differences between responders to treatment and nonresponders.
    Mine K; Okada M; Mishima N; Fujiwara M; Nakagawa T
    Biol Psychiatry; 1993 Nov; 34(9):654-60. PubMed ID: 8292695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
    Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
    Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal rhythm of 3-methoxy-4-hydroxyphenylglycol (MHPG): relationship between plasma and urinary levels.
    DeMet EM; Halaris AE; Gwirtsman HE; Reno RM
    Life Sci; 1985 Nov; 37(18):1731-41. PubMed ID: 4058250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients.
    Trestman RL; Yehuda R; Coccaro E; Horvath T; Knott P; Gabriel S; Siever LJ
    Biol Psychiatry; 1995 Apr; 37(7):448-56. PubMed ID: 7786958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards.
    Veith RC; Bielski RJ; Bloom V; Fawcett JA; Narasimhachari N; Friedel RO
    J Clin Psychopharmacol; 1983 Feb; 3(1):18-27. PubMed ID: 6833519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.